首页 | 本学科首页   官方微博 | 高级检索  
     

吸入舒利迭和思力华治疗稳定期COPD疗效观察
引用本文:马利娟,杨秀枝. 吸入舒利迭和思力华治疗稳定期COPD疗效观察[J]. 中国现代医生, 2011, 49(10): 26-27
作者姓名:马利娟  杨秀枝
作者单位:河南省开封市第一人民医院呼吸科,河南开封,475000
摘    要:目的观察舒利迭(沙美特罗替卡松粉吸入剂)和思力华(噻托溴铵粉吸入剂)联合吸人治疗稳定期慢性阻塞性肺疾病(COPD)的疗效。方法76例稳定期COPD患者随机分成两组,治疗组38例,吸入舒利迭50μg/250μg/次,2次,d,思力华18μg/1次,d;对照组38例,仅吸入舒利迭50μg/250μg/次,2次,d,治疗12周后判定疗效。结果72例患者完成实验,治疗组在临床有效率、动脉血气及肺功能的改善方面明显优于对照组(P〈0.05),用药过程中未出现严重不良反应。结论联合吸入舒利迭和思力华治疗稳定期COPD患者,可以明显改善临床症状及肺功能,效果优于单用舒利迭。

关 键 词:阻塞性肺疾病  舒利迭  思力华  吸入疗法

Observation on the Effects of Salmeterol/Fluticasone Propionate and Tiotropium Inhalation Capsules in the Treatment of Stable Chronic Obstructive Pulmonary Disease
MA Lijuan,YANG Xiuzhi. Observation on the Effects of Salmeterol/Fluticasone Propionate and Tiotropium Inhalation Capsules in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J]. , 2011, 49(10): 26-27
Authors:MA Lijuan  YANG Xiuzhi
Affiliation:MA Lijuan YANG Xiuzhi Department of Respiration,Kaifeng City First People's Hospital,Kaifeng 475000,China
Abstract:Objective To study the efficacy of salmeterol/fluticasone propionate(Seretide) and tiotropium inhalation capsules in patients with stable chronic obstructive pulmonary disease(COPD).Methods 76 patients with stable COPD were randomly divided into 2 groups.38 patients in treatment group(seretide + tiotropium),They were given Seretide(250 g/50 g) inhaling twice daily and tiotropium bromide(18 g) inhaling once daily.38 patients in control group,They were given Seretide(250 g/50 g) inhaling twice daily.The treat...
Keywords:Chronic obstructive pulmonary disease  Seretide  Tiotropium  Inhalation.  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号